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Resistance: the Health Traits Project
A.S. Leaflet R1900
D. L. Nash, Postdoctoral Research Associate, and A. E.
Freeman, Distinguished Professor of Agriculture
Introduction
As mentioned in the preceding report, marker assisted
selection for disease resistance is possible only if the marker
is associated with disease incidence. With this in mind, a
study was initiated here at Iowa State University to evaluate
potential markers for disease resistance and to look for
associations between these markers and disease incidence in
dairy cattle. This study, known as the Health Traits Project,
is being done in cooperation with Genex/CRI (Al Kuck and
Steve Schnell), producers participating in Genex’s progeny
test program, the National Animal Disease Center (Marcus
Kehrli, Jr.), and the University of Wisconsin-Madison
(George Shook).
Materials and Methods
During the first part of the Health Traits Project (Steve
Kelm’s Ph.D. dissertation research), dexamethasone was
given to 54 Holstein bulls owned by Genex that were
awaiting progeny test. Dexamethasone (a synthetic cortisol)
causes a significant, but temporary, decline in immune
response (immunosuppression). Bulls were treated with
dexamethasone so that their immune systems could imitate
the immunosuppression that occurs around calving in dairy
cows. Because the immune system is suppressed around
calving time, dairy cows tend to have more disease at this
time.
Blood samples were taken from the 54 bulls the week
before, during, and after dexamethasone treatment. These
blood samples were used to conduct 15 tests of each bull’s
immune response. Most of the tests measured the ability of
neutrophils (a type of white blood cell) to move to an
infected area and kill disease-causing organisms such as
bacteria. From these tests, it was determined that some bulls
had better immune response than others. Part of the
variation in the 54 bulls’ immune response was due to
genetic differences. The heritability of the traits measured
by the 15 tests averaged 0.35, indicating that 35% of the
variation in these traits was due to genetics.
These results indicate that AI bulls could be selected for
disease resistance based on variation in their immune
response. However, genetic improvement of disease
resistance is possible only if variation in bulls’ immune
response is related to variation in daughters’ disease
incidence. So, for the second part of the Health Traits
Project, producers are recording disease incidence
(including reproductive and metabolic disorders) on the
progeny test daughters of the 54 bulls and their herdmates.
Producers will also record treatments (includes preventative
measures such as vaccinations). Health data (disease
incidence and treatments) will be recorded from birth until
the end of first lactation or when the animal leaves the herd,
whichever comes first. These data will be compared with
the bulls’ immune response data to see whether variation in
bulls’ immune response is related to variation in daughters
disease incidence.
A total of 286 herds has recorded health data for calves
and heifers; 157 herds have recorded health data for first
lactation cows. Table 1 presents the total number of progeny
test daughters and herdmates.
Table 1. Total number of progeny test daughters and
herdmates.
Calves & heifers 1st lactation cows
Progeny test dtrs. 2,933 1,299
Herdmates 81,653 86,693
Totals 84,586 87,992
Results and discussion
Table 2 presents the most common diseases recorded in
calves and heifers and first lactation cows as a percentage of
all records of disease incidence for the age group being
considered. Together, scours and pneumonia accounted for
72% of the disease incidence in calves and heifers. Mastitis
and reproductive disorders (follicular cyst, retained
placenta, and uterine infection) accounted for 59% of the
disease incidence in first lactation cows.
Table 2. Most common diseases recorded in progeny test
herds.
   Diseases
Calves &
heifers (%)
1st lactation
cows (%)
   Coccidiosis 3
   Corn, abscess, cyst 5
   Displaced abomasum 6
   Follicular cyst 4
   Ketosis 5
   Mastitis 44
   Off feed 5 3
   Pneumonia 28 5
   Retained placenta 6
   Scours 44
   Uterine infection 5
   Other 20 17
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While producers are recording disease incidence, milk
yield and somatic cell count (SCC) data for progeny test
daughters and their herdmates are being received from
DHIA. The yield data will be used to adjust comparisons of
immune response and disease incidence for the amount of
milk produced. Yield data may also be compared with the
disease incidence data to see whether variation in cows’
disease incidence is related to variation in their milk
production. The results may provide further verification of
the reduction in disease resistance resulting from selection
for yield. The SCC data will be compared with the disease
incidence data to see whether variation in cows’ SCC is
related to variation in their disease incidence. The SCC data
will also be compared with the bulls’ immune response data
to see whether variation in daughters’ SCC is related to
variation in their sires’ immune response. The results may
provide a biological explanation of why daughters of sires
that transmit lower SCC have lower mastitis incidence.
Blood samples are also being collected from the
progeny test daughters. These blood samples will be used to
determine which copies of the Bovine Lymphocyte
Antigens (BoLA) genes daughters received from their sires.
These data will be compared with the disease incidence data
to see whether daughters receiving different copies of the
BoLA genes differ in their ability to resist disease. The
BoLA genes are partially responsible for the development
and function of the cow’s immune system (environment as
well as other genes also impact the immune system).
Animals with different copies of the BoLA genes are known
to vary in their resistance to some diseases.
If the Health Traits Project finds that variation in
immune response or the BoLA genes are related to variation
in disease incidence, then these markers may be used to
select for disease resistance. Because these markers can be
measured on bulls, dairy producers can take advantage of
them without recording disease incidence in their herds.
